Natalia Nascimento Silveira

Mrs. Natalia Nascimento Silveira

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
GPGabriele A. Pedroza
Gabriele A. Pedroza
LMLucia H.G.M.C. Macêdo
Lucia H.G.M.C. Macêdo
RORicardo de Oliveira
Ricardo de Oliveira
NSNatalia Nascimento Silveira
Natalia Nascimento Silveira
Renato Pereira OrenhaRenato Pereira Orenha
Renato Pereira Orenha
Eduardo Ferreira MolinaEduardo Ferreira Molina
Eduardo Ferreira Molina

18 September 2025 in Future Pharmacology
Verified
Journal Article
Open access
PDF file
NSNatalia Nascimento Silveira
Natalia Nascimento Silveira
AHAndrada Eduardo Heber
Andrada Eduardo Heber
JPJulia Mirian Paulino
Julia Mirian Paulino
NBNaiara Cristina da Silva Boaretto
Naiara Cristina da Silva Boaretto
Eduardo Ferreira MolinaEduardo Ferreira Molina
Eduardo Ferreira Molina
RSRaquel Alves Dos Santos
Raquel Alves Dos Santos
Backgorund/Objectives: Advances in nanotechnology have enabled conventional compounds with low bioavailability to achieve their full therapeutic potential by ensuring targeted tissue delivery. In this context, polymeric nanogels have emerged as a promising option for drug delivery due to their high loading capacity and excellent in vivo stability. Objectives: Given the growing potential of nanogels in drug delivery, their cytotoxicity and genotoxicity must be evaluated to ensure safety in biotechnological applications. This study assessed the genotoxic safety of nanogels synthesized via the reaction of Jeffamine® T-5000 polyoxypropylene triamine (PPO) monomers (Huntsman Chemical, The Woodlands, TX, USA) and poly (ethylene glycol) diglycidyl ether (DPEG) in varying proportions: 1:1 (Nano11), 1:3 (Nano13), and 2:3 (Nano23) PPO/DPEG. Additionally, we determined which of the two components exhibited lower toxicity against the CHO-K1 cell line (Chinese hamster ovary). Methods: To achieve this, short- and long-term cytotoxicity experiments were conducted using the XTT colorimetric assay and clonogenic survival assay, alongside the micronucleus test and comet assay for genotoxicity analysis. Results: The cytotoxicity assays (XTT, clonogenic, and trypan blue) indicated that the nanogels did not exhibit cytotoxic effects at concentrations up to 100 μg/mL, while the genotoxicity assays revealed no evidence of DNA or chromosomal damage at these levels. Conclusions: These findings underscore the safety profile of Jeffamine® T-5000 as an effective carrier, demonstrating its compatibility with DPEG and positioning it as a highly promising and innovative solution for advanced drug delivery systems.

21 April 2023 in Future Pharmacology
Verified
Journal Article
Open access
PDF file
JVJulia G. Vargas
Julia G. Vargas
AHAndrada Eduardo Heber
Andrada Eduardo Heber
Bruno Andrade FicoBruno Andrade Fico
Bruno Andrade Fico
JPJulia Mirian Paulino
Julia Mirian Paulino
NSNatalia Nascimento Silveira
Natalia Nascimento Silveira
Eduardo Ferreira MolinaEduardo Ferreira Molina
Eduardo Ferreira Molina
To evaluate possible structural changes and thermal stability of the polyurea unloaded and loaded with diclofenac sodium, polyurea networks based on polyetheramine containing polypropylene oxide (PPO) or polyethylene oxide (PEO) and hexamethylene diisocyanate trimer-HDI were synthesized. The formation of the network was controlled by sol-gel reactions, and the obtained materials were then characterized by different techniques (FTIR, XRD, TGA). Moreover, the amount of diclofenac released could be modulated as a function of time, studying the water absorption or swelling capacity, the cytotoxicity of the material and the amount of drug released. A choice was therefore made on the hydrophilicity of PEO- or PPO-based polyetheramine (with similar molecular weight), and the release profile was hereafter correlated with the water absorption by the PEO/PPO polyurea matrix. Links could finally be established between the release of diclofenac and the polyurea matrices properties, such as the nature of polymer (PEO/PPO) and the hydrophilicity (water uptake). Our objective here is to identify challenges and opportunities for the development of innovative functional biomaterials for health applications.

11 September 2024 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
MGMirian O. Goulart
Mirian O. Goulart
JPJulia Mirian Paulino
Julia Mirian Paulino
NSNatalia Nascimento Silveira
Natalia Nascimento Silveira
ABAriane F. Bertonha
Ariane F. Bertonha
RBRoberto G. S. Berlinck
Roberto G. S. Berlinck
RSRaquel Alves Dos Santos
Raquel Alves Dos Santos
Peptaibols are fungal peptides that exhibit efficacy against pathogen microorganisms. Trichokonin VI (TK-VI) and trichokonin VIII (TK-VIII) are known peptaibols isolated from the endolichenic fungi Hypocrea sp. Previous investigations reported that trichokonin VI presents antiproliferative effects on tumor cells. This study is pioneering in elucidating the genotoxic effects of TK-VI and TK-VIII, contributing to the thorough assessment of their safety as potential therapeutic agents. The present investigation aimed to evaluate the genotoxicity of TK-VI and TK-VIII on CHO-K1 cells. Cytotoxicity was evaluated using the XTT assay and clonogenic survival assays, followed by evaluation of DNA damage using the comet assay and micronucleus test conducted in vitro. The XTT assay results indicated IC50 values of 10.30 µM and 9.89 µM for TK-VI and TK-VIII, respectively. The clonogenic survival assay indicated that concentrations of 10 µM or higher completely inhibited the cell colony formation. In the comet assay, both TK-VI and TK-VIII increased the DNA damage score and the frequency of comet nuclei in all tested concentrations. In the micronucleus assay, TK-VI and TK-VIII at 10 µM increased the frequency of MN in CHO-K1 cells. Both TK-VI and TK-VIII exhibited genotoxic effects. Our findings underscore the importance of considering the genotoxicological safety of peptaibols, particularly when assessing their potential for other biological activities.

27 October 2026 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Open access
PDF file
DMde Melo
de Melo
MSMatheus Reis Santos
Matheus Reis Santos
ARArthur Barcelos Ribeiro
Arthur Barcelos Ribeiro
MJMarcela de Melo Junqueira
Marcela de Melo Junqueira
NSNatalia Nascimento Silveira
Natalia Nascimento Silveira
DTDenise Crispim Tavares
Denise Crispim Tavares
Breast cancer is the most common malignant neoplasm among women and exhibits high molecular heterogeneity, which directly influences therapeutic response and clinical outcomes. Despite advances in targeted therapies and immunotherapies, tumor recurrence, resistance to conventional treatments, and metastatic potential reinforce the need for more selective and effective pharmacological strategies. In this context, metal complexes, particularly ruthenium(II) derivatives, have attracted considerable attention due to their antitumor profile, greater selectivity, and lower systemic toxicity. Therefore, in the present study, the antineoplastic activity of the RuMTZ complex (2-mercaptothiazoline-di-1,2-bis(diphenylphosphine)ethane-ruthenium(II)) was evaluated in three breast cancer cell lines (MDA-MB-231, MDA-MB-468 and MCF7) and in one non-tumor breast cell line (MCF10A). RuMTZ exhibited greater cytotoxicity against human MDA-MB-468 cells, as demonstrated by cell viability (IC 50 = 1.8 µM) and clonogenic (IC 50 = 0.08 µM) assays, associated with higher selectivity indexes (3.89 and 3.75, respectively). Further studies demonstrated that RuMTZ inhibited cell migration by up to 62.76% and induced cell-cycle arrest in the G0/G1 phase, accompanied by a reduction in the G2/M population. Furthermore, the ruthenium complex induced apoptotic cell death, as observed by flow cytometry and increased levels of cleaved caspase-3 by Western blot. The genotoxic effect of RuMTZ was evidenced by the comet assay and increased γH2AX expression levels. Taken together, these findings demonstrate that RuMTZ exhibits promising antineoplastic activity against breast cancer cells, associated with cell-cycle arrest, induction of DNA damage, and apoptosis.